200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 15920-93-1

15920-93-1

15920-93-1 | L-Alanine, 3-(methylamino)-

CAS No: 15920-93-1 Catalog No: AG001QK9 MDL No:MFCD00055227

Product Description

Catalog Number:
AG001QK9
Chemical Name:
L-Alanine, 3-(methylamino)-
CAS Number:
15920-93-1
Molecular Formula:
C4H10N2O2
Molecular Weight:
118.1344
MDL Number:
MFCD00055227
IUPAC Name:
(2S)-2-amino-3-(methylamino)propanoic acid
InChI:
InChI=1S/C4H10N2O2/c1-6-2-3(5)4(7)8/h3,6H,2,5H2,1H3,(H,7,8)/t3-/m0/s1
InChI Key:
UJVHVMNGOZXSOZ-VKHMYHEASA-N
SMILES:
CNC[C@@H](C(=O)O)N
UNII:
108SA6URTV

Properties

Complexity:
84.1  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
118.074g/mol
Formal Charge:
0
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
118.136g/mol
Monoisotopic Mass:
118.074g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
75.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.8  

Literature

Title Journal
Excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons. Toxicon : official journal of the International Society on Toxinology 20121101
Reactivity of β-methylamino-L-alanine in complex sample matrixes complicating detection and quantification by mass spectrometry. Analytical chemistry 20120918
Weak BMAA toxicity compares with that of the dietary supplement β-alanine. Neurobiology of aging 20120701
The non-protein amino acid β-N-methylamino-L-alanine in Portuguese cyanobacterial isolates. Amino acids 20120601
Selective LC-MS/MS method for the identification of BMAA from its isomers in biological samples. Analytical and bioanalytical chemistry 20120601
Analytical techniques for the detection of α-amino-β-methylaminopropionic acid. The Analyst 20120507
Shark fin consumption may expose people to neurotoxic BMAA. Environmental health perspectives 20120501
Elucidation of matrix effects and performance of solid-phase extraction for LC-MS/MS analysis of β-N-methylamino-L-alanine (BMAA) and 2,4-diaminobutyric acid (DAB) neurotoxins in cyanobacteria. The Analyst 20120307
Synergistic toxicity of the environmental neurotoxins methylmercury and β-N-methylamino-L-alanine. Neuroreport 20120307
Reversed-phase HPLC/FD method for the quantitative analysis of the neurotoxin BMAA (β-N-methylamino-L-alanine) in cyanobacteria. Toxicon : official journal of the International Society on Toxinology 20120301
The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease? Environmental health perspectives 20120301
Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Marine drugs 20120201
The effect of exogenous β-N-methylamino-L: -alanine on the growth of Synechocystis PCC6803. Microbial ecology 20120101
Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20120101
A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteria. PloS one 20120101
Determination of the non protein amino acid β-N-methylamino-l-alanine in estuarine cyanobacteria by capillary electrophoresis. Toxicon : official journal of the International Society on Toxinology 20111001
Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration? International journal of environmental research and public health 20110901
Nitrogen starvation of cyanobacteria results in the production of β-N-methylamino-L-alanine. Toxicon : official journal of the International Society on Toxinology 20110801
Amyotrophic lateral sclerosis: one or multiple causes? Neurology international 20110406
The effect of β-N-methylamino-L-alanine (BMAA) on oxidative stress response enzymes of the macrophyte Ceratophyllum demersum. Toxicon : official journal of the International Society on Toxinology 20110401
Washed cycad flour contains β-N-methyl amino-L-alanine and may explain parkinsonism symptoms. Annals of neurology 20110201
β-N-Methylamino-L-alanine (BMAA) uptake by the aquatic macrophyte Ceratophyllum demersum. Ecotoxicology and environmental safety 20110101
The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Toxins 20101201
Distinguishing the cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB). Toxicon : official journal of the International Society on Toxinology 20101101
β-N-methylamino-L-alanine induces neurological deficits and shortened life span in Drosophila. Toxins 20101101
Cycas micronesica (Cycadales) plants devoid of endophytic cyanobacteria increase in beta-methylamino-L-alanine. Toxicon : official journal of the International Society on Toxinology 20100915
Development and application of a comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method for the analysis of L-beta-methylamino-alanine in human tissue. Journal of chromatography. A 20100702
Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Toxicon : official journal of the International Society on Toxinology 20100501
Metabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-Methylamino-L-alanine on substantia nigra pars compacta DAergic neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 20100414
Selective death of cholinergic neurons induced by beta-methylamino-L-alanine. Neuroreport 20100106
LC-MS/MS determination of the isomeric neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius. Toxicon : official journal of the International Society on Toxinology 20100101
Analytical protocol for identification of BMAA and DAB in biological samples. The Analyst 20100101
Effects of the cyanobacterial neurotoxin beta-N-methylamino-L-alanine on the early-life stage development of zebrafish (Danio rerio). Aquatic toxicology (Amsterdam, Netherlands) 20091213
Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine. Toxicological sciences : an official journal of the Society of Toxicology 20091101
Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue. Toxicology and applied pharmacology 20091015
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta neurologica Scandinavica 20091001
Liquid chromatographic determination of the cyanobacterial toxin beta-n-methylamino-L-alanine in algae food supplements, freshwater fish, and bottled water. Journal of food protection 20090801
Augmentation and ionic mechanism of effect of beta-N-methylamino-L-alanine in presence of bicarbonate on membrane potential of Retzius nerve cells of the leech Haemopis sanguisuga. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20090701
A mutation in the Proteosomal Regulatory Particle AAA-ATPase-3 in Arabidopsis impairs the light-specific hypocotyl elongation response elicited by a glutamate receptor agonist, BMAA. Plant molecular biology 20090701
Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (beta-N-methylamino-L-alanine) following neonatal administration to rodents. Toxicological sciences : an official journal of the Society of Toxicology 20090601
beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-). Experimental neurology 20090601
Cycad seeds and chronic neurologic disease (Cycas species). Disease-a-month : DM 20090601
beta-N-methylamino-L-alanine induced in vivo retinal cell death. Journal of neurochemistry 20090501
Lack of cerebral bmaa in human cerebral cortex. Neurology 20090414
1H NMR determination of beta-N-methylamino-L-alanine (L-BMAA) in environmental and biological samples. Toxicon : official journal of the International Society on Toxinology 20090401
The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 20090203
The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 20090203
The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 20090203
Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy. Pigment cell & melanoma research 20090201
Improving derivatization efficiency of BMAA utilizing AccQ-Tag in a complex cyanobacterial matrix. Amino acids 20090101
Beta-methylamino-L-alanine analysis by liquid chromatography tandem mass spectrometry with iTRAQ as the derivative. European journal of mass spectrometry (Chichester, England) 20090101
Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Previous studies underestimate BMAA concentrations in cycad flour. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Consumption of fa cai Nostoc soup: a potential for BMAA exposure from Nostoc cyanobacteria in China? Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Mechanisms of beta-N-methylamino-L-alanine induced neurotoxicity. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
BMAA neurotoxicity in Drosophila. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Toxicity of the cyanobacterial neurotoxin beta-N-methylamino-L-alanine to three aquatic animal species. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease? Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Determination of the neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (alpha-,gamma-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101
Determination of the neurotoxin BMAA (beta-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry). The Analyst 20081201
Beta-N-methylamino-L-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicology and environmental safety 20081001
Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA. Journal of ethnopharmacology 20080619
Effective determination method for a cyanobacterial neurotoxin, beta-N-methylamino-L-alanine. Toxicon : official journal of the International Society on Toxinology 20080601
Co-occurrence of beta-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. Environmental microbiology 20080301
Animal models of BMAA neurotoxicity: a critical review. Life sciences 20080130
Toxin types, toxicokinetics and toxicodynamics. Advances in experimental medicine and biology 20080101
Conventional laboratory methods for cyanotoxins. Advances in experimental medicine and biology 20080101
[Revisit to Kii ALS--the innovated concept of ALS-Parkinsonism-dementia complex, clinicopathological features, epidemiology and etiology]. Brain and nerve = Shinkei kenkyu no shinpo 20071001
Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm. Neurochemistry international 20070601
Characterization of ethyl chloroformate derivative of beta-methylamino-L-alanine. Journal of the American Society for Mass Spectrometry 20070501
Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo. Neurotoxicology 20070501
Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiology of disease 20070201
Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropathology and applied neurobiology 20061201
A nonprotein amino acid and neurodegeneration. Science (New York, N.Y.) 20061124
Acute perfusion of BMAA in the rat's striatum by in vivo microdialysis. Toxicology letters 20061101
Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins. Movement disorders : official journal of the Movement Disorder Society 20061001
Debating the cause of a neurological disorder. Science (New York, N.Y.) 20060922
BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Experimental neurology 20060901
Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide? Science (New York, N.Y.) 20060728
Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. Journal of ethnopharmacology 20060615
Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice. Pharmacology, biochemistry, and behavior 20060601
Sporadic amyotrophic lateral sclerosis as an infectious disease: a possible role of cyanobacteria? Medical hypotheses 20060101
Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology 20050913
Putative neurotoxin ecologically widespread. The Lancet. Neurology 20050601
Electrophysiological effect of beta-N-methylamino-L-alanine on retzius nerve cells of the leech Haemopis sanguisuga. Annals of the New York Academy of Sciences 20050601
Environmental neurotoxin may pose health threat. JAMA 20050525
The Lathyrus excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid is a substrate of the L-cystine/L-glutamate exchanger system xc-. Toxicology and applied pharmacology 20041015
Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta neurologica Scandinavica 20041001
Food chain of evidence points to brain toxin. JAMA 20031203
Western Pacific ALS/PDC and flying foxes: What's next? Neurology 20030812
Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 20030812
Expressed sequence tag analysis in Cycas, the most primitive living seed plant. Genome biology 20030101
The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. Journal of ethnopharmacology 20021001
Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 20020326
A pharmacological characterization of the mGluR1 alpha subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line. Brain research 19930813

© 2019 Angene International Limited. All rights Reserved.